Search

Search results

69 results found

A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder.

Suppes, Trisha, Susan L McElroy, David Sheehan V, Rosario B Hidalgo, Victoria E Cosgrove, Iola S Gwizdowski, and Natalie S Feldman. 2014. “A Randomized, Double-Blind, Placebo-Controlled Study of Ziprasidone Monotherapy in Bipolar Disorder With Co-Occurring Lifetime Panic or Generalized Anxiety Disorder.”. The Journal of Clinical Psychiatry 75 (1): 77-84.

Comparing Region of Interest versus Voxel-Wise Diffusion Tensor Imaging Analytic Methods in Mild and Moderate Traumatic Brain Injury: A Systematic Review and Meta-Analysis.

Hunter, Liane E, Naomi Lubin, Nancy R Glassman, Xiaonan Xue, Moshe Spira, and Michael L Lipton. 2019. “Comparing Region of Interest versus Voxel-Wise Diffusion Tensor Imaging Analytic Methods in Mild and Moderate Traumatic Brain Injury: A Systematic Review and Meta-Analysis.”. Journal of Neurotrauma 36 (8): 1222-30.

Can treatment response to SGLT2-inhibitors in syndrome of inappropriate antidiuresis be predicted by copeptin, natriuretic peptides and inflammatory markers?

Nobbenhuis, Rianne, Julie Refardt, Deborah Vogt, Clara O Sailer, Bettina Winzeler, and Mirjam Christ-Crain. 2021. “Can Treatment Response to SGLT2-Inhibitors in Syndrome of Inappropriate Antidiuresis Be Predicted by Copeptin, Natriuretic Peptides and Inflammatory Markers?”. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals 26 (7): 647-55.

Psychopathological characteristics in patients with arginine vasopressin deficiency (central diabetes insipidus) and primary polydipsia compared to healthy controls.

Atila, Cihan, Julia Beck, Julie Refardt, Zoran Erlic, Juliana B Drummond, Clara O Sailer, Matthias E Liechti, et al. 2024. “Psychopathological Characteristics in Patients With Arginine Vasopressin Deficiency (central Diabetes Insipidus) and Primary Polydipsia Compared to Healthy Controls.”. European Journal of Endocrinology 190 (5): 354-62.